Liraglutide, semaglutide, and tirzepatide demonstrated significant weight loss (greater than 5%).This study highlights that newer anti-diabetic drugs, particularly GLP1-RA (glucagon-like peptide-1 receptor agonists) and Tirzepatide, are highly effective in promoting weight loss among patients with type 2 diabetes
Ghusn W, Hurtado MD (2024) Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Originally developed to manage type 2 diabetes and obesity, GLP-1 RAs are showing unexpected promise in reducing inflammation, slowing kidney damage, and protecting against cardiovascular risks in lupus patients
You also have continued access to a trusted resource if life changes, such as a new job, travel, pregnancy, or menopause, affect your weight or health
Research Chemicals: Some sellers offer tirzepatide for research purposes only, which are not pharmaceutical-grade and not safe for human consumption